Tendinopathy Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies – MiMedx Group, Ipsen, and others

Tendinopathy Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MiMedx Group, Ipsen, and others

“Delveinsight Business Research LLP”
DelveInsight’s “Tendinopathy Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Tendinopathy Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Tendinopathy market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Tendinopathy Market

Tendinopathy: An Overview

Tendinopathy describes a complex multifaceted pathology of the tendon, characterized by pain, decline in function and reduced exercise tolerance. The most common overuse tendinopathies involve the rotator cuff tendon, medial and lateral elbow epicondyles, patellar tendon, gluteal tendons, and the Achilles tendon.

Tendinopathy symptoms include pain, swelling, and reduced function. The prominent histological and molecular features of tendinopathy include disorganization of collagen fibers, an increase in the microvasculature and sensory nerve innervation, dysregulated extracellular matrix homeostasis, increased immune cells, and inflammatory mediators, and enhanced cellular apoptosis.

Tendinopathy Market Key Facts

  • In a study by Forde et al., 2005 the most commonly diagnosed musculoskeletal disorders were tendinopathies (19%) and ruptured disks in the back (18%), shoulder bursopathies (15%), and carpal tunnel syndrome (12%)

  • According to a study by Ackermann, 2015 the incidence of tendinopathy is rising in the developed world because of increased participation in recreational sports. Around 30% of all runners exhibit Achilles tendinopathy, with an annual incidence of 7% to 9%.

  • As per the estimates by DelveInsight, the incidence of lower extremity Tendinopathy is higher than upper extremity Tendinopathy.

Tendinopathy Market

Tendinopathy Market is expected to grow in the coming years owing to the rising cases in 7MM. A better disease understanding and advancement in therapeutic management are also anticipated to boost the growth of the therapeutic market.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Tendinopathy market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Tendinopathy market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Tendinopathy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Tendinopathy Epidemiology Segmentation

  • Total incident cases of Tendinopathy

  • Total diagnosed and treatable cases of Tendinopathy

  • Age-specific cases of Tendinopathy

  • Type-specific cases of Tendinopathy

Tendinopathy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Tendinopathy market or expected to get launched during the study period. The analysis covers Tendinopathy market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Tendinopathy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/tendinopathy-market

Tendinopathy Therapeutics Analysis

The current emerging landscape for Tendinopathy is limited, mainly comprising Phase II and Phase III candidate drugs. The key players for phase II and III clinical development are MiMedx Group, Ipsen, and others.

Tendinopathy Therapies covered in the report include:

  • Micronized dHACM – Micronized dHACM is a dehydrated Human Amnion Chorion Membrane Injection that is derived from donated human placentae and has anti-inflammatory, low immunogenic, and anti-fibrotic properties. Currently, it is being evaluated in phase III for the treatment of Achilles Tendonitis.

  • Dysport 500 – Ipsen is collaborating with University Hospital, Bordeaux to evaluate Dysport 500 Unit Powder for Injection in the treatment of tendinopathy.

Some of the key companies in the Tendinopathy Market include:

  • MiMedx Group, Inc.

  • Ipsen

And many others

Get More Detailed Insights Into the Emerging Therapies & Key Companies –  https://www.delveinsight.com/sample-request/tendinopathy-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Tendinopathy Competitive Intelligence Analysis

4. Tendinopathy Market Overview at a Glance

5. Tendinopathy Disease Background and Overview

6. Tendinopathy Patient Journey

7. Tendinopathy Epidemiology and Patient Population

8. Tendinopathy Treatment Algorithm, Current Treatment, and Medical Practices

9. Tendinopathy Unmet Needs

10. Key Endpoints of Tendinopathy Treatment

11. Tendinopathy Marketed Products

12. Tendinopathy Emerging Therapies

13. Tendinopathy Seven Major Market Analysis

14. Attribute Analysis

15. Tendinopathy Market Outlook (7 major markets)

16. Tendinopathy Access and Reimbursement Overview

17. KOL Views on the Tendinopathy Market.

18. Tendinopathy Market Drivers

19. Tendinopathy Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/tendinopathy-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance. 


Other Healthcare Reports by DelveInsight

Thalassemia Market
“Thalassemia Market” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Thalassemia Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/